Your browser doesn't support javascript.
loading
Glycemic deviation index: a novel method of integrating glycemic numerical value and variability.
Zou, Yizhou; Wang, Wanli; Zheng, Dongmei; Hou, Xu.
Affiliation
  • Zou Y; Department of Endocrinology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, 324 Jing 5 Road, Jinan, 250021, China.
  • Wang W; Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
  • Zheng D; Shandong Clinical Medical Center of Endocrinology and Metabolism, Jinan, China.
  • Hou X; Institute of Endocrinology and Metabolism, Shandong Academy of Clinical Medicine, Jinan, China.
BMC Endocr Disord ; 21(1): 52, 2021 Mar 19.
Article de En | MEDLINE | ID: mdl-33736619
ABSTRACT

BACKGROUND:

There are many continuous blood glucose monitoring (CGM) data-based indicators, and most of these focus on a single characteristic of abnormal blood glucose. An ideal index that integrates and evaluates multiple characteristics of blood glucose has not yet been established.

METHODS:

In this study, we proposed the glycemic deviation index (GDI) as a novel integrating characteristic, which mainly incorporates the assessment of the glycemic numerical value and variability. To verify its effectiveness, GDI was applied to the simulated 24 h glycemic profiles and the CGM data of type 2 diabetes (T2D) patients (n = 30).

RESULTS:

Evaluation of the GDI of the 24 h simulated glycemic profiles showed that the occurrence of hypoglycemia was numerically the same as hyperglycemia in increasing GDI. Meanwhile, glycemic variability was added as an independent factor. One-way ANOVA results showed that the application of GDI showed statistically significant differences in clinical glycemic parameters, average glycemic parameters, and glycemic variability parameters among the T2D groups with different glycemic levels.

CONCLUSIONS:

In conclusion, GDI integrates the characteristics of the numerical value and the variability in blood glucose levels and may be beneficial for the glycemic management of diabetic patients undergoing CGM treatment.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Glycémie / Diabète de type 2 Type d'étude: Etiology_studies / Risk_factors_studies Aspects: Patient_preference Limites: Adult / Aged / Female / Humans / Male / Middle aged Pays/Région comme sujet: Asia Langue: En Journal: BMC Endocr Disord Année: 2021 Type de document: Article Pays d'affiliation: Chine

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Glycémie / Diabète de type 2 Type d'étude: Etiology_studies / Risk_factors_studies Aspects: Patient_preference Limites: Adult / Aged / Female / Humans / Male / Middle aged Pays/Région comme sujet: Asia Langue: En Journal: BMC Endocr Disord Année: 2021 Type de document: Article Pays d'affiliation: Chine